{"url_path":"/sec/bctx/8-k/2026-06-03/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-03","source_url":"https://www.sec.gov/Archives/edgar/data/1610820/0001493152-26-026953-index.html","accession_number":"0001493152-26-026953","cik":"0001610820","ticker":"BCTX","issuer_name":"BriaCell Therapeutics Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1610820/0001493152-26-026953-index.html","primary_entity_key":"0001610820","primary_entity_name":"BriaCell Therapeutics Corp."},"word_count":62,"has_tables":true,"body_markdown":"**Item\n8.01 Other Events.**\n\n \n\nOn\nMay 31, 2026, the Company issued a press release announcing the pricing of the Offering.\n\n \n\nOn\nJune 2, 2026, the Company issued a press release announcing the closing of the Offering.\n\n \n\nCopies\nof the press releases are attached as Exhibits 99.1 and 99.2 respectively, to this Current Report on Form 8-K and are incorporated herein\nby reference."}